The Federal Supply Schedule (FSS) contract awarded to Sterisyn Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) is for the provision of pharmaceuticals, drugs, and hematology-related products to support VA healthcare programs for veterans nationwide. The multiple-award contract has a potential value of $360,000 through April 2024 and allows the company to deliver various drug products, including gabapentin, TYVASO, and naproxen, to VA facilities and VA...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to STI Pharma LLC, a for-profit limited liability company and manufacturer of goods, on August 15, 2017, with a ceiling value of $225,000.00 and a period of performance through May 14, 2026. The contract is part of the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, a multiple-award...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Verity Pharmaceuticals, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB schedule, with a contract ceiling value of $225,000.00 and a period of performance through November 30, 2026. The...
The key information from the provided federal contract IDV award is as follows: The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Federal Supply Schedule (FSS) contract to Stratus Pharmaceuticals Inc., a minority-owned, small disadvantaged, woman-owned business, to provide drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contract has a ceiling value of $14,425,700 and a period of performance from October 1, 2023 through September...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Tetraphase Pharmaceuticals Inc., a for-profit organization and subsidiary of La Jolla Pharmaceutical Company. The contract is for the procurement of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract is a multiple-award, unrestricted (no set-aside) vehicle with...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
The U.S. Department of Veterans Affairs (VA) has awarded a $198 million Federal Supply Schedule (FSS) contract and a $50 million Blanket Purchase Agreement (BPA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. These Indefinite Delivery Vehicles (IDVs) allow the VA to efficiently procure United Therapeutics' specialized drug portfolio, including treatments for pulmonary arterial hypertension and certain types of cancer,...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for VHA facilities. The prime contractor is Vyne Pharmaceuticals Inc., doing business as Menlo Therapeutics, with a potential value of $225,000 over the period of performance from August 2020 through August 2022. The contract was...